Introduction of 23WELL Ovary Care Capsules by Andall Biosciences Inc. at Circle Harmony, Shanghai

Andall Biosciences Inc. (ABI) has recently unveiled their groundbreaking new product line, 23WELL, with the introduction of their Ovary Care Capsules (1+1) at Circle Harmony in InterContinental Shanghai Ruijin. This innovative product has already received approval from the U.S. FDA, showcasing ABI’s commitment to bridging the gap between therapeutic and preventative treatments for a healthier future.

Inspired by the 23 chromosomes that make up life, 23WELL combines advanced life science research with natural ingredients to create health supplements that promote overall well-being. The brand’s meticulous selection process ensures only the finest raw materials are used, and the capsules are produced in a facility that meets strict standards for quality.

ABI’s Founder and Chief Research Officer, Helen Li, emphasizes the importance of reproductive health for women and the need to shift the self-care paradigm to include holistic well-being. The Ovary Care Capsules (1+1) aim to integrate state-of-the-art medical technologies with natural ingredients to promote global health and well-being.

The product highlights include the use of advanced ingredients like Myo-Inositol, Coenzyme Q10, and Vitamins E and D, along with traditional Chinese elements such as Gallus Domesticus Peptide and Astragalus Root Extract. ABI’s commitment to innovation and quality is evident in their entry into the Chinese market and their dedication to empowering individuals to achieve vitality and well-being.

With a focus on integrating traditional Chinese and Western medicines, ABI’s 23WELL brand represents a groundbreaking achievement in women’s health. By addressing issues like premature ovarian insufficiency, ABI is paving the way for a brighter and healthier future for women worldwide. For more information on ABI and their products, visit https://www.andall-health.com.